Sensitive detection of Cre-mediated recombination using droplet digital PCR reveals Tg(BGLAP-Cre) and Tg(DMP1-Cre) are active in multiple non-skeletal tissues by Dasgupta, Krishnakali et al.
1 
Sensitive detection of Cre-mediated recombination using droplet digital PCR reveals 
Tg(BGLAP-Cre) and Tg(DMP1-Cre) are active in multiple non-skeletal tissues.   
Krishnakali Dasgupta PhD1,2, Samantha Lessard BS1, Steven Hann PhD1, Megan A. Fowler 
BA1, Alexander G. Robling PhD3, Matthew L. Warman MD1,2 
1. Orthopedic Research Laboratories, Department of Orthopedic Surgery, Boston Children’s
Hospital, Boston, MA 
2. Department of Genetics, Harvard Medical School, Boston, MA
3. Indiana University School of Medicine, Indianapolis, IN
Correspondence to: 
Matthew L. Warman, M.D. 
Orthopedic Research Labs, EN250 
Boston Children’s Hospital 
320 Longwood Avenue 
Boston, MA 02115 
Phone: 617-919-2371 
Email: matthew.warman@childrens.harvard.edu 
Supplementary Materials: Supplementary Figures 1 - 7; Supplementary Tables 1 and 2 
_______________________________________________
This is the author's manuscript of the article published in final edited form as:
Dasgupta, K., Lessard, S., Hann, S., Fowler, M. E., Robling, A. G., & Warman, M. L. (2021). Sensitive detection 
of Cre-mediated recombination using droplet digital PCR reveals Tg(BGLAP-Cre) and Tg(DMP1-Cre) are active 
in multiple non-skeletal tissues. Bone, 142, 115674. https://doi.org/10.1016/j.bone.2020.115674
2 
Abstract 
     In humans, somatic activating mutations in PIK3CA are associated with skeletal overgrowth.  
In order to determine if activated PI3K signaling in bone cells causes overgrowth, we used 
Tg(BGLAP-Cre) and Tg(DMP1-Cre) mouse strains to somatically activate a disease-causing 
conditional Pik3ca allele (Pik3caH1047R) in osteoblasts and osteocytes. We observed Tg(BGLAP-
Cre);Pik3caH1047R/+ offspring were born at the expected Mendelian frequency.  However, these 
mice developed cutaneous lymphatic malformations and died before 7 weeks of age.  In 
contrast, Tg(DMP1-Cre);Pik3caH1047R/+ survived and had no cutaneous lymphatic malformations.  
Assuming that Cre-activity outside of the skeletal system accounted for the difference in 
phenotype between Tg(BGLAP-Cre);Pik3caH1047R/+ and Tg(DMP1-Cre);Pik3caH1047R/+ mice, we 
developed sensitive and specific droplet digital PCR (ddPCR) assays to search for and quantify 
rates of Tg(BGLAP-Cre)- and Tg(DMP1-Cre)-mediated recombination in non-skeletal tissues.  
We observed Tg(BGLAP-Cre)-mediated recombination in several tissues including skin, muscle, 
artery, and brain; two CNS locations, hippocampus and cerebellum, exhibited Cre-mediated 
recombination in >5% of cells. Tg(DMP1-Cre)-mediated recombination was also observed in 
muscle, artery, and brain. Although we cannot preclude differences in phenotype between mice 
with Tg(BGLAP-Cre)- and Tg(DMP1-Cre)-mediated PIK3CA activation being due their inducing 
Cre-recombination at different stages of osteoblast differentiation, differences in recombination 
at non-skeletal sites of are the more likely explanation.   Since unanticipated sites of 
recombination can affect the interpretation of data from experiments involving conditional 
alleles, we recommend ddPCR as a good first step for assessing efficiency, leakiness, and off-
targeting in experiments that employ Cre-mediated or Flp-mediated recombination. 
Key words: Mouse, Osteoblasts, Osteocytes, Osteocalcin, BGLAP, Cre-recombination, 
PIK3CA  
Introduction 
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    Congenital Lipomatous Overgrowth with Vascular, Epidermal and Skeletal anomalies 
(CLOVES) syndrome is a non-heritable congenital overgrowth syndrome caused by somatic 
activating mutations in PIK3CA, the gene which encodes a catalytic subunit of the enzyme 
phosphatidyl-inositol-3 phosphate kinase (PI3K)(2).  Intracellular signaling via class 1 PI3K 
enzymes normally occurs in response to ligand-dependent activation of receptor tyrosine 
kinases, including the vascular endothelial growth factor receptor and insulin-like growth factor 
receptor (3).  Effector proteins, that function downstream of PI3K signaling, include the AKT (Ak 
strain transforming) and mTOR (mammalian target of rapamycin) proteins, which are involved in 
cell proliferation and survival(4).  Also in this signaling pathway is the enzyme PTEN 
(phosphatase and tensin homologue deleted on chromosome 10), which is a phosphatase that 
reverses the action of PI3K(5). 
    Among the intriguing features of CLOVES syndrome, and other disorders within the PIK3CA-
related overgrowth spectrum, is localized overgrowth of limbs or digits that are composed of 
cells having endodermal, mesodermal, and ectodermal origins(6,7). Because CLOVES is caused 
by somatic mutation, it seems unlikely that an early embryonic mutation would affect multiple 
cell lineages all ending up in a single limb or digit.  More likely, is that a somatic mutation in the 
progenitor of one cell type drives overgrowth of other tissues via paracrine signaling.  The 
importance of PI3K signaling in osteoblasts was inferred from studies that used Tg(BGLAP-Cre) 
to inactivate Pten in osteoblasts, which led to increased bone mass(8).  Here, we used 
Tg(BGLAP-Cre) and Tg(DMP1-Cre) to conditionally activate a gain-of-function Pik3ca allele in 
osteoblasts and osteocytes.   
    Mice with Tg(BGLAP-Cre)- and Tg(DMP1-Cre)-mediated activation of Pik3ca had very 
different phenotypes, but no appendicular overgrowth. The difference in phenotypes is likely due 
to the transgenic Cre drivers causing Cre-mediated recombination at sites other than bone. 
Since many experiments utilize conditional alleles, and unanticipated sites of recombination can 
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affect data interpretation, we developed a droplet digital PCR (ddPCR) method that is sensitive, 
specific, rapid, and cost-effective for determining sites and levels of Cre-mediated 
recombination.   
Materials and Methods  
Mouse strains and husbandry 
    The Institutional Animal Care and Use Committee at Boston Children’s Hospital approved all 
animal experiments.  Mice with Tg(BGLAP-Cre)(9), Tg(DMP1-Cre)(10), R26mTmG (11), and R26l-s-
lLacZ (12) alleles were purchased from the Jackson Laboratory (JAX stock #s 019509, 023047, 
007676, and 003474).  Pik3caH1047R mice(13) were obtained from Dr. Wayne Phillips at the Peter 
McCallum Institute in Melbourne Australia.  Cells from Pik3caH1047R mice express wild-type 
PIK3CA until Cre-recombination causes expression of a constitutively active form of this 
enzyme. Mice with Prg4GT alleles were created and maintained in our lab(14), and are available 
from the Jackson Lab (JAX stock # 025740). 
    Hemizygous male Tg(BGLAP-Cre) mice were crossed with female Pik3caH1047R/H1047R, 
R26mTmG/mTmG, R26l-s-lLacZ/l-s-lLacZ, or Prg4GT/GT mice.  Hemizygous Tg(DMP1-Cre) males were 
crossed with Pik3caH1047R/+ mice.  Offspring were genotyped as previously described and, after 
weaning, maintained with same sex littermates. Tg(BGLAP-Cre);Pik3caH1047R/+ offspring were 
monitored daily because their clinical phenotype warranted early euthanasia.  Some Tg(BGLAP-
Cre);Pik3caH1047R/+ offspring and offspring from the other crosses were euthanized at 14, 18, 21, 
24, 27, 28, 34, or 60 days of age for tissue collection.  Tg(DMP1-Cre);Pik3caH1047R/+ offspring 
displayed no overt phenotype and were euthanized at 3 months of age. 
Sample collection and DNA extraction   
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    Twenty-one-day-old mutant (Tg(BGLAP-Cre);Pik3caH1047R/+) and control (Pik3caH1047R/+) mice 
were given anesthesia using 2% isoflurane and subjected to retro-orbital blood collection using 
heparinized and non-heparinized capillary tubes.  Blood samples were sent to the small animal 
core lab at Boston Children’s Hospital for automatic blood cell counting and biochemical 
analyses, respectively.  
   Twenty-one-day-old mutant (Tg(BGLAP-Cre);Pik3caH1047R/+, Tg(BGLAP-Cre);R26mTmG/+ and 
Tg(BGLAP-Cre);Prg4GT/+), and  control (Pik3caH1047R/+, R26mTmG/+ and Prg4GT/+) mice were 
euthanized. Thirty different tissues, including calvarial bone, 5th lumbar vertebra, cerebral 
cortex, dorsal cerebellum, midbrain representing the junction of the cerebral cortex and superior 
colliculi, skin overlying the 5th lumbar vertebra, tongue, clavotrapezius (neck) muscle, femoral 
artery, ovary, testis, liver and kidney were immediately collected and stored at -20°C.  
Approximately 20 mg of each tissue was used to extract genomic DNA using the Qiagen Blood 
and Tissue DNA extraction kit.  Extracted DNA was stored in water, quantified using Nanodrop 
technology, and kept at -20°C.  Separate femoral and vertebral bones were also dissected, 
cleaned of soft tissue, fixed for 1 week in 4% paraformaldehyde (PFA), and then transferred to 
70% ethanol.  We collected 11 different tissues from Tg(DMP1-Cre);Pik3caH1047R/+, Tg(DMP1-
Cre);Pik3ca+/+, Pik3caH1047R/+, and wild-type littermates.  Femora, skulls, and vertebral bones 
were also collected from 3-month-old Tg(DMP1-Cre);Pik3caH1047R/+ and Tg(DMP1-Cre);Pik3ca+/+ 
mice. 
Histologic sectioning, LacZ staining, and Immunohistochemistry  
    Heads from Tg(BGLAP-Cre);R26l-s-lLacZ/+ and R26l-s-lLacZ/+ littermates were recovered from P14, 
P34, and P60 animals.  After the skin was gently removed the specimens were fixed in 4% PFA 
for 10 minutes followed by 2 washes in 1X phosphate buffered saline (PBS).  The specimens 
were then equilibrated sequentially in 15% Sucrose/PBS overnight and 30% Sucrose/PBS 
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overnight at 4OC, embedded in OCT, frozen on dry ice, cryosectioned at 10 µm and stored at -
80°C.   Other heads from Tg(BGLAP-Cre);Pik3caH1047R/+, Tg(DMP1-Cre);Pik3caH1047R/+ and 
control mice were stored in Bouin’s fixative prior to embedding, sectioning, and hematoxylin and 
eosin staining by the rodent histology core at Harvard Medical School. 
    LacZ staining was performed by thawing sections at room temperature for 10 min, immersing 
the slides for 10 min each in: 0.2% glutaraldehyde/2mM MgCl2/PBS, then 1X PBS, then 2mM 
MgCl2/PBS, and then 2mM MgCl2/PBS/0.01%DOC/0.02%NP-40.  All steps were performed in 
solutions kept on ice.  Slides were then immersed in 0.1% X-Gal/2mM MgCl2/0.01% DOC/02% 
NP-40/1.05% Potassium HexacyanoFerrate(II)/0.825% Potassium Ferricyanide (III)/PBS, 
wrapped in aluminum foil and incubated in the dark for at least 8 hours at 37°C.  Slides were 
then rinsed in PBS, fixed in 4% PFA for 2 hours at room temperature, rinsed again in PBS and 
then counterstained for 2 minutes with Nuclear Fast Red stain solution. After gently rinsing in 
water, the slides were dehydrated sequentially with ethanol (50% -1 min, 70% - 1min, 100% - 1 
min X 2) followed by xylene (2 min X 3). After mounting in Permount (Fisher Scientific) and 
cover-slipping, the slides were then dried for two more days. 
    Immunodetection of Phospho-mTor was performed on P18 6µm coronally sectioned 
Tg(BGLAP-Cre);Pik3caH1047R/+ and Pik3caH1047R/+ heads that were prepared for cryosectioning as 
described above and immediately fixed in ice-cold acetone for 5 min and air dried.  Endogenous 
peroxidase activity was quenched using 3% hydrogen peroxide in methanol for 20 min. After 3 
washes with Tris buffered saline (TBS), a rabbit monoclonal anti-Phospho-mTOR(Ser2448) 
antibody (Cell Signaling #2976) at 1 to 350 dilution using the TSA kit’s TNB buffer (Perkin 
Elmer) was overlayed onto the sections and incubated overnight at 4°C.  After 3 washes with 
TBS/0.5% Tween20, a horse radish peroxidase (HRP)-conjugated goat anti-rabbit secondary 
antibody (Jackson Immunoresearch) at dilution 1 to 400 in TNB buffer was added for 30 min at 
room temperature. After 3 washes with TBS/0.5% Tween20, amplification of signal was done 
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using the TSA kit with biotinylated tyramide and streptavidin HRP following the manufacturer’s 
recommendation.  Diaminobenzidine was used as the chromophore with hematoxylin 
counterstaining.  
  Tartrate resistant acid phosphatase (TRAP) staining of long bone sections was performed as 
previously described(15). 
    Photomicrographs were obtained using a Nikon Eclipse 80i microscope at 40X and 100X - 
magnification, and captured with a Nikon digital sight DSRi1 camera using the NIS Elements 
software.  Quantitative histomorphometry for osteoblasts and osteoclasts is reported using 
standard nomenclature(16). 
Bone µCT and fluorochrome labeling of mineralizing tissue 
    Femoral and vertebral bone µCT imaging, and fluorochrome labeling with fluorescence 
imaging, were performed as previously described(17).  
Droplet digital PCR 
    Droplet digital PCR was performed as previously described(1).  Briefly, DNA was diluted to a 
concentration of ~ 10 ng/µl, and ~ 30 ng of DNA was used in each reaction.  Supermix for 
Probes mastermix (BioRad) was used following the manufacturer’s recommendations.  PCR 
was performed using Eppendorf ep gradient S machines, nanodroplets were created using an 
automatic droplet generator, amplimer containing droplets were counted with a QX200 sample 
reader, and data were analyzed using Quantasoft software (all from BioRad). The primer pairs 
and probes described below were purchased from IDT (Coralville, IA) and were used to amplify 
and quantify the number conditional and recombined alleles.  At least 1000 amplimer containing 
droplets per tissue sample per animal were created in order to measure Cre-mediated 
recombination. 
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    For the Pik3caH1047R allele: Two PCR primers 19For-25:CAAGGGAGAGGAATGGTAAGG 
and mut20R-BamH1: CAACTCAGGCATGCCGGATCCCAA generated a 719 bp amplimer for 
from the conditional allele and a 265 bp amplimer from the recombined allele. The conditional 
allele was detected using a 5HEX/CGAAGTTATTTGTTAGACCCTT/3IABkFQ probe, while the 
recombined allele was detected using a 56-
FAM/CGAAGTTATGTTAACTTGTTAGACC/3IABkFQ probe.   The PCR reaction was 
95°C/10mins, followed by 40 cycles of 94°C/30s; 56°C/60s; 72°C/60s, followed by 98°C/10mins 
until cooling to 4°C.  The cycling ramp time was 1.2s/°C.  
    For the R26mTmG allele (Figure 2): Three PCR primers, p9104: 
CCATGTTCATGCCTTCTTCTT, p9102: TGATGACCTCCTCTCCCTTG, and 
p9107:TGCTCACGGATCCTACCTTC generated a 238 bp amplimer for the conditional allele 
and a 331 bp amplimer for the recombined allele. The conditional allele was detected using a 
5HEX/CGAAGTTATATTAAGGGTTCCGGATCC/3IABkFQ probe, while the recombined allele 
was detected using a 56-FAM/TCCGGATCATCACCGCGGATGGGT/3IABkFQ probe.  The 
PCR reaction was the same as above, except the primer annealing temperature was 55°C. 
    For the Prg4GT allele: Three PCR primers 5’loxp-f: TGTGTTGACAGTCGACATATAACTTCG, 
insert-r:TCTAGGACAAGAGGGCGAGA,  and wt-r:AAGGAAGAGAGAGCATTGAAGG 
generated a 304 bp amplimer for the conditional allele and a 226 bp amplimer for the 
recombined allele.  The conditional allele was detected using a 
5HEX/TCGGTTCCTCTTCCCATGAATTCCA/3IABkFQ probe, while the recombined allele was 
detected using a 56-FAM/TCCCCTCGAGGGACCTAATAACTTCGT/3IABkFQ probe. The PCR 
reaction was the same as above, except the primer annealing temperature was 58°C. 
Results 
Tg(BGLAP-Cre)-mediated activation of PI3K signaling causes early lethality in mice. 
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    In order to generate mice in which PI3K activity is constitutively active in osteoblasts and 
osteocytes, hemizygous male Tg(BGLAP-Cre) mice were bred to Pik3caH1047R/H1047R  females. 
Pik3caH1047R produces wild-type protein until Cre-mediated recombination induces mutant 
protein expression.  Equal numbers of Tg(BGLAP-Cre);Pik3caH1047R/+ and Pik3caH1047R/+ offspring 
were born.  Pups did not appear phenotypically different during the 1st week of life and had 
similar long bone histology (Supplementary Figure 1).  By ~ 2 weeks of age, Tg(BGLAP-
Cre);Pik3caH1047R/+ mice were smaller (Figure 1A) and less active than their Pik3caH1047R/+ 
littermates, and they had swelling over the surface of their skulls.  Histologic examination 
revealed enormous lymphatic channels in the skin overlying the head (Figure 1B) and blood 
clots were detected between the skin and calvarium by necropsy.  Tg(BGLAP-
Cre);Pik3caH1047R/+ mice died spontaneously or required euthanasia before 7 weeks of age 
(Figure 1D).  No other abnormalities of major organs including heart, lung, liver, kidney, intestine 
and brain were observed on gross or microscopic inspection. The presence of clotted blood and 
the knowledge that the bone microenvironment can affect hematopoiesis(18-20), prompted us to 
perform blood profiles on Tg(BGLAP-Cre);Pik3caH1047R/+ mice when they were 3 weeks of age; 
numbers of white blood cells, red blood cells, platelets, and bleeding times were normal (data 
not shown).  Since bone cells have been reported to directly and indirectly regulate systemic 
energy metabolism and ion homeostasis(21,22), we also measured serum glucose, electrolytes, 
calcium, phosphorus, albumin, total protein, alkaline phosphatase, urea, and creatinine levels in 
3-week-old Tg(BGLAP-Cre);Pik3caH1047R/+  and control (Pik3caH1047R/+) littermates, and saw no 
differences (data not shown).  Lastly, since Tg(BGLAP-Cre);Ptenfl/fl mice were previously found 
to develop increasing bone mass with aging(8), we examined bone mass in Tg(BGLAP-
Cre);Pik3caH1047R/+ mice using µCT and fluorochrome labeling.  These animals had less femoral, 
calvarial, and vertebral bone than their control littermates (Figure 1C, Supplementary Figures 2 
and 3, Supplementary Table 1). Calcein labeling indicated bone mineralization was still 
occurring in P24 mutant and control animals. However, the proliferating and hypertrophic 
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chondrocyte zones in the growth plates of the mutant mice appeared smaller than those of their 
control littermates (Supplementary Figure 3).  TRAP staining for osteoclasts and quantification 
of osteoclast and osteoblast numbers revealed no difference between Tg(BGLAP-
Cre);Pik3caH1047R/+ and Pik3caH1047R/+ littermates at P0 (data not shown), but a significant 
reduction in the number of osteoblasts and osteoclasts in Tg(BGLAP-Cre);Pik3caH1047R/+ 
compared to Pik3caH1047R/+ littermates at P27 (Supplementary Figure 4). 
 
 
Figure 1.  Impaired growth, reduced bone 
mass, and early lethality in Tg(BGLAP-
Cre);Pik3caH1047R/+ mice.   
(A) Photographs comparing 2-week-old 
Pik3caH1047R/+ and Tg(BGLAP-
Cre);Pik3caH1047R/+ littermates.  Note 
Tg(BGLAP-Cre);Pik3caH1047R/+ mice are 
smaller and have swelling over the cranium 
(arrowhead).  (B) Representative 40X 
photomicrographs of hematoxylin and eosin 
stained sections through the external ears of 
control Tg(DMP1-Cre) and mutant 
Tg(BGLAP-Cre);Pik3caH1047R/+ mice.  Ear 
cartilage is indicated with arrows. Note the 
multiple enlarged lymphatic channels 
(asterisks) between the cartilage and the 
epidermis in the mutant mice (C) Transverse 
µCT reconstructions of the distal femur of 4-
week-old Pik3caH1047R/+ and Tg(BGLAP-
Cre);Pik3caH1047R/+ littermates.  Note the 
Tg(BGLAP-Cre);Pik3caH1047R/+ mouse bone 
has few trabeculae. (D)  Kaplan-Meier plot 
following Pik3caH1047R/+ and Tg(BGLAP-
Cre);Pik3caH1047R/+ mice (N = 13 
animals/genotype).  Note all Tg:BGLAP-
Cre;Pik3caH1047R/+ mice died before 7 weeks 
of age. 
 11  
 
Tg(DMP1-Cre)-mediated activation of PI3K signaling is not lethal. 
    To exclude the possibility that lymphatic swelling over the skull was a direct effect of Pik3ca 
activity in bone cells, we studied Tg(DMP1-Cre);Pik3caH1047R/+ mice.  These animals did not die 
early, had normal skin, and had thicker skull bones than control mice (Supplementary Figure 5).  
Mean midshaft femur cortical bone volume was also significantly higher in the Tg(DMP1-
Cre);Pik3caH1047R/+ mice compared to littermate controls  (1.22 mm2 vs. 0.96 mm2, p < 0.01, n = 
3 mice/genotype). 
Tg(BGLAP-Cre) recombines conditional (i.e., floxed) alleles in multiple tissues. 
    Because early lethality in Tg(BGLAP-Cre);Pik3caH1047R/+ mice was not clearly attributable to 
osteoblast dysfunction, we looked for Cre-mediated recombination in other tissues where 
constitutive activation of PI3K signaling would be detrimental.  Studies have reported that 
activating the Pik3caH1047R allele in endothelial cells causes venous(23) and lymphatic(24) 
malformations.  Activation in the central nervous system can cause early lethality or seizures(25), 
and global activation in adult mice causes death from hypoglycemia within several weeks(26).  
We collected multiple tissues from 3-week-old Tg(BGLAP-Cre);Pik3caH1047R/+ mice to look for 
Tg(BGLAP-Cre) mediated recombination outside of the skeletal system. Age matched 
littermates (i.e., Pik3caH1047R/+) that lack the BGLAP-Cre transgene were controls for testing the 
specificity of the assay. We used ddPCR, which is a sensitive tool for detecting low levels of 
somatic mosaicism(1,27,28).  Thus, if the Tg(BGLAP-Cre) were active in non-bone tissues, ddPCR 
would detect “off-target” recombination.  Recombination rates for 8 different tissues from 3-
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9.8 1.2 27.6 0.5 19.8 3.8 21.1 2.1 
23.9 0.8 15.6 2.0 25.8 0.1 29.7 1.6 




14.5 2.8 8.3 0.3 14.27 4.74 11.7 1.8 
12.4 0.5 6.1 0.4 8.05 2.19 17.4 0.8 




6.66 0.4 0.7 0.1 9.9 0.5 11.2 5.4 
1.34 0.2 6.9 1.1 2.1 3.2 3.2 1.5 




2.58 0.8 5.8 0.9 1.1 0.5 1.1 0.3 
7.03 1.1 0.6 0.3 5.1 1.6 0.5 0.3 




8.1 0.5 0.6 0.0 1.8 0.4 0.1 0.0 
7.5 0.4 0.5 0.2 1.5 0.2 0.5 0.3 




3.4 0.3 0.7 0.4 1.1 0.1 10.2 2.1 
5.4 0.4 0.6 0.0 1.2 0.2 12.1 0.4 




3.2 0.5 0.4 0.3 0.6 0.1 1.8 0.1 
2.9 0.3 0.1 0.0 0.5 0.1 2.7 0.4 




0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 
0.0 0.0     0.0 0.1 0.0 0.0 
	
Table 1 legend: Tg(BGLAP-Cre)-mediated recombination in 3-week-old mice and 
Tg(DMP1-Cre)-mediated recombination in 3-month-old mice.  
Recombination frequencies were measured by ddPCR.  DNA was recovered from the same 
sites in 2 or 3 mice (each row represents 1 mouse) having 1 of 3 different (Pik3caH1047R, 
R26mTmG, or Prg4GT) floxed alleles (each column represents one of the conditional alleles).  
All ddPCR assays were performed in triplicate; the mean recombination frequency ± 
standard deviation (SD) for each experiment is shown.  No conditional or recombined 
droplets were detected when either water or wild-type mouse DNA was used as template 
(Supplementary Table 2).  Additionally, no recombined droplets were detected when DNA 
from mice with conditional alleles alone (i.e., no Tg(BGLAP-Cre) allele) was used as 
template (Supplemental Table 1); since a minimum of 1000 amplimer-containing droplets 
from each tissue was analyzed, these results indicate the ddPCR assays are highly specific.   
When DNAs from mice with a conditional allele and the Tg(BGLAP-Cre) transgene were 
assayed, recombination was detected in several but not all tissues. In this table, 
representative examples are shown. Recombined allele frequencies greater than 0.5%, 
which exceeds a conservative threshold we previously employed for calling true positives(1), 
are bolded.    Tissue-specific differences in recombination frequency between animals with 
the same genotype may reflect biologic variation or sampling error due to the tissues having 
diverse cell types that are mosaic for the recombined allele.  Of note, similar levels of 
recombination were detected in the midbrains and cerebellums of floxed mice, irrespective 
of the conditional allele. In contrast, the Cre-recombination frequency was higher in skin, 
tongue, and femoral artery from Tg(BGLAP-Cre); Pik3caH1047R/+ mice, which is consistent 
with cells containing mutant PI3K having a proliferative advantage in these tissues.  
Nevertheless, in skin and in tongue Tg(BGLAP-Cre) still caused recombination at rates of ~ 
1-in-200 to ~ 1-in-75, in mice with R26mTmG, or Prg4GT alleles, respectively.  Tg(DMP1-Cre) 
also caused recombination in several non-skeletal tissues. 
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    Neither water controls, nor DNA from wild-type mice or from mice with only the Pik3caH1047R 
allele had evidence of recombination [Supplementary Table 2], indicating this ddPCR assay is 
highly specific. Calvarial and vertebral DNA from Tg(BGLAP-Cre);Pik3caH1047R/+ mice contained 
recombined alleles.  Importantly, several other tissues from Tg(BGLAP-Cre);Pik3caH1047R/+ mice 
also contained recombined alleles.  For example, recombined alleles were observed in ~ 9% of 
skin cells, ~ 5% of midbrain cells, ~ 5% of cerebellar cells, and ~ 5% of clavotrapezius muscle 
cells (Table 1). 
    In addition to causing CLOVES syndrome and other malformation disorders when arising 
during embryogenesis(1), the p.H1047R mutation in PIK3CA is a common somatic mutation that 
arises in cancer(29). Thus, recombination in non-skeletal tissues of Tg(BGLAP-Cre);Pik3caH1047R/+ 
mice could be very low, with the abundance of recombined cells increasing over time because 
they have a proliferative advantage.  To test this hypothesis, we bred the Tg(BGLAP-Cre) into 
two other mouse strains, in which Cre-mediated recombination would not give recombined cells 
a proliferative advantage.  This would enable us to differentiate tissues that have appreciable 
amounts of Tg(BGLAP-Cre) “off-target” expression from those that have very low levels of “off-
target” expression that appear high because of increased cell proliferation.   
    Hemizygous male Tg(BGLAP-Cre) mice were bred to female mice homozygous for Prg4GT or 
R26mTmG.  The Prg4GT allele is a loss-of-function allele at the lubricin locus that restores lubricin 
expression after Cre-recombination(14).  Presence or absence of lubricin should have no effect 
on cell proliferation in brain, muscle, and skin.  The R26mTmG allele ubiquitously expresses 
membrane-bound tomato fluorescent protein (mTFP) until Cre-recombination changes 
expression to membrane bound green fluorescent protein (mGFP)(11).  This allele is commonly 
used to visualize sites of Cre-mediated recombination using fluorescence microscopy 
(https://www.jax.org/strain/007676), since the switching from mTFP to mGFP is not thought to 
alter cell proliferation or viability.  
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    Droplet digital PCR data derived from DNA extracted from 3-week-old Tg(BGLAP-
Cre);R26mTmG/+ (Figure 2) and Tg(BGLAP-Cre) ;Prg4GT/+ mice are included in Table 1.   
    Age-matched littermates lacking the Cre transgene served as negative controls. As with the 
Pik3caH1047R ddPCR assay, these ddPCR assays are highly specific since no recombined 
amplimer-containing droplets were observed when DNA from mice with the conditional allele 
alone was used as ddPCR template [Supplementary Table 2].  Importantly, midbrain and 
cerebellar cells from Tg(BGLAP-Cre);R26mTmG/+ and Tg(BGLAP-Cre);Prg4GT/+ mice continued to 
demonstrate significant levels of Cre-mediated recombination (Table 1).  Also, although lower 
than in mice with the conditional Pik3caH1047R allele, Cre-mediated recombination still occurred in 
skin and muscle of mice with Prg4GT or R26mTmG/+ alleles.  Hence, the Tg(BGLAP-Cre) allele 
expresses catalytically active Cre-recombinase in multiple non-skeletal tissues. 
    We also looked for non-skeletal expression of Cre-recombinase in 3-month-old Tg(DMP1-
Cre);Pik3caH1047R/+ mice (Table 1).  Interestingly, recombination rates exceeding 10% were 
observed in muscle, and rates exceeding 5% were seen in artery and midbrain.  However, in 
contrast to Tg(BGLAP-Cre);Pik3caH1047R/+ mice which had recombination rates > 6% in skin at 3-
weeks-old, Tg(DMP1-Cre);Pik3caH1047R/+ mice had only 0.2% recombination 
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in 
Figure 2. The ddPCR assay for the R26mTmG allele.   
(Upper panels) Schematic diagrams (not to scale) of the conditional and Cre-recombined 
mTmG alleles.  The locations of the primers and probes used in the ddPCR assay are 
indicated.  Note in the conditional allele, primers 9104 and 9107 are too far apart to produce 
PCR product that is detected using the mT or mG probe.  (Lower panels) ddPCR assay 
results obtained using DNA extracted from calvarium, midbrain, and clavotrapezius muscle in 
a 20-day-old Tg(BGLAP-Cre);R26mTmG/+ mouse.  Droplets lacking amplimers are 
pseudocolored black.  Droplets containing amplimers from the conditional allele (channel 2 
positive) are pseudocolored green, while droplets containing amplimers from the recombined 
allele (channel 1 positive) are pseudocolored blue.  The percentage of amplimer-containing 
droplets (conditional or recombined) that have a recombined allele is indicated beneath each 
tissue.  No amplimer-containing droplets were observed in the water control.  In neck muscle, 
3409 droplets containing amplimer from the conditional allele were observed.  In midbrain, 49 
droplets containing amplimer from the recombined allele and 804 droplets containing 
amplimer from the conditional allele were observed. 
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skin at 3-months-old. 
Tg(BGLAP-Cre) expression localizes to subsets of cells within the central nervous system.   
    Droplet digital PCR indicated that Tg(BGLAP-Cre) is active in the CNS.  To determine which 
cells had expressed the Tg(BGLAP-Cre) allele, hemizygous male Tg(BGLAP-Cre) mice were 
bred to female mice homozygous for the R26l-s-lLacZ allele.  Tg(BGLAP-Cre);R26l-s-lLacZ/+ and R26l-
s-lLacZ/+ littermate offspring were then euthanized at different postnatal ages, and their heads 
were sectioned coronally and stained for β-galactosidase activity.   No CNS staining was 
observed in P0 mice (data not shown).  At P14, the age when Tg(BGLAP-Cre);Pik3caH1047R/+ 
mice begin to appear different from their littermates, β-galactosidase activity was seen in 
granule cells of the dentate gyrus and in some CA3 pyramidal neurons of the hippocampus of 
Tg(BGLAP-Cre);R26l-s-lLacZ/+ mice, and not in the corresponding regions of control mice (Figure 
3A-F).  This pattern of Tg(BGLAP-Cre)-mediated recombination in the hippocampus extends 
from its anterior to posterior region. Additionally, β-galactosidase activity was detected in the 
granular cells of the cerebellar gyri of Tg(BGLAP-Cre);R26l-s-lLacZ/+  mice (Figure 3G - N).  
Furthermore, the number of LacZ expressing cells in the cerebellar gyri appeared to increase as 
the animals aged (Figure 3K and M). 




    To determine if Tg(BGLAP-Cre);Pik3caH1047R/+ mice had increased PI3K activity in Cre-
recombined CNS cells, we performed immunohistochemistry using an anti-Phospho-mTOR 
antibody.  At P18, compared to a Pik3caH1047R/+ littermate control, the Tg(BGLAP-
Cre);Pik3caH1047R/+ mouse had increased Phospho-mTor immunoreactivity in many cerebellar 
granule cells (Supplementary Figure 6).  Increased phospho-mTor immunoreactivity was also 
Figure 3. Tg(BGLAP-Cre) is active in mouse hippocampus and cerebellum.  
(Left panels) Photomicrographs of coronal sections through the hippocampi of P14, P34, 
and P60 Tg(BGLAP-Cre);R26l-s-lLacZ/+ and R26l-s-lLacZ/+ littermates.  Each section is stained for 
β-galactosidase activity.  Note LacZ expressing cells are present only in granule cells (black 
arrowheads) of the dentate gyrus (dg) and in CA3 pyramidal neurons (white arrowhead) of 
Tg(BGLAP-Cre);R26l-s-lLacZ/+ mice.  (Right panels) Photomicrographs of coronal sections 
through the cerebellums of P14, P34, and P60 Tg(BGLAP-Cre);R26l-s-lLacZ/+ and R26l-s-lLacZ/+ 
littermates.  Each section is stained for β-galactosidase activity.  Note only cells in the 
granular (gr) layer and not the molecular (mo) layer of the cerebellum express LacZ in 
Tg(BGLAP-Cre);R26l-s-lLacZ/+ mice.  Furthermore, the fraction of LacZ expressing cells in the 
cerebellar granular cells appears to increase with age.  All scalebars are 500 µm, except for 
scalebars in panels I and J, which represent the boxed areas from panels I and H and are 
100 µm. 
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observed in most calvarial bone cells from the Tg(BGLAP-Cre);Pik3caH1047R/+ mouse and not in 
the control littermate (Supplementary Figure 7).  
Discussion  
    Tg(BGLAP-Cre)  mice were generated more than a decade ago by cloning a 3.5 kb DNA 
human BGLAP regulatory element upstream of Cre-recombinase and injecting into fertilized 
eggs(9).  Tg(BGLAP-Cre) mice were generously donated to the Jackson Lab for public 
distribution and have been used in dozens of studies (https://www.jax.org/strain/019509) 
assessing the consequence of recombining loxP flanked (floxed) alleles in osteoblasts and 
osteocytes.  Cell-type specific expression of the BGLAP-Cre transgene was inferred from 
northern blots looking for Cre mRNA expression, from Southern blots and PCR assays that 
looked for recombination of floxed alleles, and from fluorescence microscopy using reporter 
mouse strains (e.g.,(8,9,30)).   However, these assays examined limited numbers of tissues and 
were insensitive to low levels of Cre expression or low levels of Cre-mediated recombination.  
Thus, data from these studies does not preclude Tg(BGLAP-Cre) being active at non-skeletal 
sites.  Nevertheless, there remains a misconception that BGLAP-Cre expression is restricted to 
osteoblasts and osteocytes(30).  In contrast, expression we found outside of the skeletal system 
for Tg(DMP1-Cre), such as in muscle and brain, has previously been observed by us and other 
investigators(17,31-33).  
   In bone, in addition to osteoblasts and osteocytes, Tg(BGLAP-Cre) expression has been 
observed in arteriolar pericytes and Cxcl12-associated reticular cells(33). Here we show that 
Tg(BGLAP-Cre) is also more broadly expressed, and we describe a ddPCR method to identify 
and quantify Cre-mediated recombination in tissues and cells.  We suspected Tg(BGLAP-Cre) 
had “off-target" (i.e., non-bone) expression because Tg(BGLAP-Cre);Pik3caH1047R/+ mice 
developed profound lymphatic enlargement with hemorrhage overlying their skulls, failed to gain 
weight, and died by 7 weeks of age.   After excluding bone-derived hematologic and metabolic 
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causes for the early lethality, we looked for activated PI3K signaling in other tissues that have 
been associated with deleterious effects in humans and mice.  We utilized ddPCR(34), a powerful 
method for detecting low frequency somatic mutations, and found Tg(BGLAP-Cre)-mediated 
recombination in multiple tissues, including skin, brain, and muscle.  Interestingly, Tg(BGLAP-
Cre) expression appeared localized to specific brain regions such as hippocampus and 
cerebellum (Figure 3), and was not apparent at birth.  Also, with respect to CNS expression of 
Tg(BGLAP-Cre), we observed comparable levels of Cre activity (Table 1) in mice having 
different floxed alleles (e.g., R26mTmG and Prg4GT). 
    At present, we do not know why Tg(BGLAP-Cre);Pik3caH1047R/+ mice die and have a  
phenotype that is different from that of mice with Tg(BGLAP-Cre)-induced loss-of-function 
mutations in Pten (8).   Several possibilities may account for this difference.  First, PIK3CA may 
signal via some pathways that are not regulated by PTEN.  Second, PIK3CA activation requires 
recombination of only 1 allele, whereas PTEN inactivation requires recombination of 2 alleles.  
Third, mRNA transcripts encoding 2 other catalytic subunits of the PI3 kinase signaling pathway, 
PIK3CB and PIK3CD, are expressed in bone(15); these subunits may be responsible for 
increasing bone mass in PTEN deficient mice and/or for mitigating the effects of PIK3CA over-
activity.  However, the similarity between Tg(BGLAP-Cre)-mediated PTEN loss-of-function and 
Tg(DMP1-Cre)-mediated PIK3CA gain-of-function mice, with regard to their survival and 
increased bone mass, suggests the difference in phenotype between the Tg(BGLAP-Cre) and 
Tg(DMP1-Cre) mice is due to their having non-overlapping extraskeletal sites of Cre-
recombination.  Large lymphatic malformations seen in Tg(BGLAP-Cre);Pik3caH1047R/+, and not 
in Tg(DMP1-Cre);Pik3caH1047R/+, mice may be responsible for the former animals’ early lethality, 
since similar malformations can be debilitating and deadly in humans(35). 
    We do not know whether Tg(BGLAP-Cre) expression in the brain reflects endogenous sites 
of osteocalcin production, ectopic transgene expression due to sequences in the transgene 
itself, or ectopic transgene expression due to the site of transgene integration.  BGLAP 
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transcripts are present in human brain RNA-sequencing data 
(https://www.gtexportal.org/home/gene/BGLAP), and Bglap expression has also been reported 
in rat brain(36).   Mice have three Bglap paralogs located on chromosome 3(37).  Two paralogs are 
highly expressed in bone, while the third is not expressed in bone but is expressed in other 
tissues including brain(37).  In situ hybridization studies reveal expression of at least one Bglap 
paralog in mouse brain (http://mouse.brain-map.org/gene/show/11881).  
    Regardless of the mechanism(s) responsible for determining where Tg(BGLAP-Cre) is 
expressed, our data indicate this transgene is not bone-specific.  Therefore, investigators should 
consider off-target sites of Cre-recombinase activity when interpreting, or re-interpreting, data 
that have been generated with these mice.  Many strains of Cre-driver mice have unanticipated 
sites of Cre-expression, and mice with inducible Cre-recombinase activity (e.g., Tet-On and 
tamoxifen-inducible systems) can become active without induction (i.e., leakiness)(38). 
Furthermore, an animal’s genetic background and the floxed allele being recombined can also 
influence Cre-recombinase expression, leakiness, or efficiency.  Similar considerations apply to 
mice that express Flp-recombinase.   
    Several methods are available to detect unanticipated sites of Flp- or Cre- activity and to 
quantify rates of recombination, including using mice with fluorescent or enzymatic reporters 
that can be assessed by microscopic imaging, or performing quantitative PCR using allele 
specific fluorescent reporter probes.  We prefer using ddPCR.  Although the fluorescent reporter 
probe cost is identical to that of quantitative PCR, we find ddPCR assays are simple to set up, 
sensitive, and specific.  Advantages of performing ddPCR before using mouse strains with 
fluorescent or enzymatic reporter alleles, are the ability of ddPCR to quantify recombination 
rates for any allele of interest, not just the reporter allele, and to detect low levels of 
recombination that may be missed if a histologically examined section didn’t include the region 
of a tissue that contains recombined cells.  We were conservative in considering recombination 
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frequencies < 0.5% as potentially representing false positive results based on our prior work 
with other ddPCR assays(1).  However, the assays described herein are highly specific, 
suggesting the threshold for detecting true recombination, particularly for commonly used 
reporter alleles, such as R26mTmG, is much lower.  It is also important to recognize that we found 
differences in recombination frequency when the same tissue was recovered from animals with 
the same genotype (Table 1).  We suspect these differences reflect sampling variation between 
animals since each tissue is actually comprised of multiple cell types for which only a subset of 
cells may contain recombined alleles; however, we cannot preclude the differences we 
observed among genetically matched animals being true biologic variation.  With ddPCR it 
becomes possible to quantify recombination in multiple tissues/sites using DNA derived from 
thousands of cells in each tissue.  Furthermore, ddPCR can be used on DNA recovered from 
formalin fixed tissues and histologic sections, enabling analysis of experiments in which 
samples have been archived.  When unexpected Cre or Flp recombination occurs, fluorescence 
and histochemical methods can then be employed to determine the identities of the recombined 
cells. 
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Highlights 
 BGLAP-Cre and DMP1-Cre transgenes are expressed in unexpected locations in mice. 
 Off-target recombination can confound interpretation of data using these transgenes. 
 ddPCR detects and quantifies allele-specific, off-target recombination events.  
